How Training Simulations Will Help Pharma Sales Teams in the Post-Pandemic Market

06/09/2021 By Andrea

Article contributed to PharmaLeaders and authored by: Jeremy Lovelace, founder and director of HFX Training. Across all industries, sales teams face an uncertain future, and pharma is no different. Many key sales practices, such as healthcare provider meetings and terrority-focused engagement have been replaced by the unfamiliar environment of zoom calls, emails and remote […]

Healthcare M&A on the Rise: 5 Principles for Creating a New Brand that Resonates

05/18/2021 By Andrea

Article contributed to PharmaLeaders by Matt Egan, Executive Director, Strategy at Siegel+Gale A wave of M&A deals is coming to the healthcare industry. According to consulting firm BDO, 44% of healthcare CFOs are expecting to drive an increase in partnerships across the healthcare ecosystem and 42% are predicting further consolidation. The pandemic accelerated digital and […]

EMA’s CHMP approves Moderna’s new Covid-19 vaccine manufacturing site in France

06/23/2021

Biotechnology company Moderna has secured approval from the European Medicines Agency’s (EMA) committee for human medicines (CHMP) for a new Covid-19 vaccine manufacturing site in Monts, France. Addition The post EMA’s CHMP approves Moderna’s new Covid-19 vaccine manufacturing site in France … [Read More...]

GSK, iTeos Therapeutics to co-develop and co-commercialise cancer drug

06/23/2021

TIGIT, a part of the CD226 checkpoint axis, has shown potential as a promising target for the next generation of immuno-oncology therapies based on preclinical data and a The post GSK, iTeos Therapeutics to co-develop and co-commercialise cancer drug appeared first on Pharmaceutical Business … [Read More...]

European Commission buys additional doses of Moderna’s Covid-19 vaccine

06/23/2021

The European Commission has purchased an additional 150 million Moderna’s Covid-19 vaccine doses, bringing its confirmed order commitment to 460 million doses. The deal also includes an option The post European Commission buys additional doses of Moderna’s Covid-19 vaccine appeared first on … [Read More...]

ViiV Healthcare, Halozyme partner to develop HIV medicines

06/23/2021

ViiV Healthcare has signed a global collaboration and license agreement with Halozyme Therapeutics to develop “ultra-long-acting” medicines for HIV. The deal gives exclusive access to Halozyme’s ENHANZE drug The post ViiV Healthcare, Halozyme partner to develop HIV medicines appeared first on … [Read More...]

Featured Article

How Training Simulations Will Help Pharma Sales Teams in the Post-Pandemic Market

Healthcare M&A on the Rise: 5 Principles for Creating a New Brand that Resonates

White Papers

Managing the Shifting Currents of Customer Master Data

Improving HCP Attendance

Industry News

EMA’s CHMP approves Moderna’s new Covid-19 vaccine manufacturing site in France

GSK, iTeos Therapeutics to co-develop and co-commercialise cancer drug

European Commission buys additional doses of Moderna’s Covid-19 vaccine

ViiV Healthcare, Halozyme partner to develop HIV medicines